ロード中...
Acquired and intrinsic resistance in cancer immunotherapy
A number of immunotherapies, in particular immune checkpoint targeting antibodies and adoptive T‐cell therapies, are starting to transform the treatment of advanced cancers. The likelihood to respond to these immunotherapies differs strongly across tumor types, with response rates for checkpoint tar...
保存先:
| 出版年: | Mol Oncol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528612/ https://ncbi.nlm.nih.gov/pubmed/25106088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.07.011 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|